baber/WOPTO huggingface dataset:
Patent AU-2002300433-B2 (AU)
Title: Grinding Wheel
Inventor: CHEVALIER JEAN-PIERRE
IPC: B24D7/06
Filed: 2002-08-07
Granted: 2007-09-13
Abstract: The grindstone has a receiving region (2), a central grinding region (1) with through apertures (3) and cutting bodies (4) at different spacings. The long side (5) of each cutting body facing the central receiving region is at and angle of 35-55 degrees to a radius (R) originating in the central receiving region, at a tangent to an edge (K) formed from the long side and the wide side (6) of the cutting body facing away from the entral receiving region.
Patent AU-2002323650-B2 (AU)
Title: Prostaglandin compositions and methods of treatment for male erectile dysfunction
Inventor: YEAGER JAMES L
IPC: A61K9/00
Filed: 2002-09-06
Granted: 2007-12-13
Abstract: The invention provides methods of treating erectile dysfunction comprising the step of placing within the fossa navicularis of the patient an effective erection-inducing amount of a prostaglandin E1 composition of a semi-solid consistency, as well as suitable applicators. The composition comprises prostaglandin E1, a penetration enhancer, a polysaccharide gum, a lipophilic compound, and an acidic buffer system. The penetration enhancer is an alkyl-2-(N,N-disubstituted amino)-alkanoate ester, an (N,N-disubstituted amino)-alkanol alkanoate, or a mixture of these. The lipophilic compound may be an aliphatic C1 to C8 alcohol, aliphatic C2 to C30 ester, an aliphatic C8 to C30 ester, or a mixture of these. The composition includes a buffer system capable of providing a buffered pH value for said composition in the range of about 3 to about 7.4.
Patent AU-2003204169-B2 (AU)
Title: Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid
Inventor: MALIN MICHAEL J
IPC: G01N33/48
Filed: 2003-05-14
Granted: 2005-04-14
Abstract: The present invention describes semi- and fully-automated methods and reagents therefor for the assay and analysis of body fluid samples, particularly non-blood samples. The methods and reagents are especially useful for the assay and analysis of cerebrospinal fluid (CSF) samples. The reagent compositions sphere and fix all cells in the sample in suspension. Reported results can include red blood cell (RBC) and white blood cell (WBC) counts, WBC differential values, cell-by-cell volumes and dry-mass concentrations.
Patent AU-2003215983-B2 (AU)
Title: A trailer for a boat
Inventor: GRANLIND HANS INGMAR
IPC: B60P3/10
Filed: 2003-03-03
Granted: 2007-10-25
Abstract: A trailer adaped for a boat that includes a U-shaped chassis having wheels and a number of struts supported by the chassis and slings or the like oriented between struts coordinated in pairs is described. The slings support the boat by abutting against an outer surface of a boat hull. Also, the chassis may be formed by two flexurally rigid branches, each one turnably related and connected with a connecting part of a first end portion of each branch. Further selected struts may consist of one hydraulic piston-cylinder arrangement each. The piston-cylinder arrangements are hydraulically interconnected such that hydraulic oil may be distributed under an overpressure between the arrangements, in correlation with the rocking and/or rolling motion of the hull, including the twisting motion of the branches in relation to the ground and the twisting motion thereof in relation to the connecting part.
Patent AU-2003221922-B2 (AU)
Title: Intracranial treatment of neuropsychiatric disorders by clostridial neurotoxins such as botulinum toxin
Inventor: DONOVAN STEPHEN
IPC: A61P25/00
Filed: 2003-04-11
Granted: 2006-09-28
Abstract: Methods for treating psychiatric disorders include intracranial administration of a therapeutically effective amount of a neurotoxin, such as a botulinum toxin type A, to a human patient.
Patent AU-2003226579-B2 (AU)
Title: Azabicyclo derivatives as muscarinic receptor antagonists
Inventor: SHETTY SHANKAR JAYRAM
IPC: A61K31/4523
Filed: 2003-04-11
Granted: 2009-01-22
Abstract: This invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. Specifically, the invention relates to derivatives of azabicyclo compounds, including, for example, 6-substituted azabicyclo[3.1.0] hexanes, and 2,4,6-trisubstituted derivatives. The invention also relates to pharmaceutical compositions containing the compounds and the methods of treating the diseases mediated through muscarinic receptors.
Patent AU-2003231248-B2 (AU)
Title: Vascularization enhanced graft constructs
Inventor: BADYLAK STEPHEN FRANCIS
IPC: A61L27/38
Filed: 2003-05-01
Granted: 2009-03-05
Abstract: A tissue graft construct for use in repairing diseased or damaged tissues is provided. The tissue graft construct comprises a matrix composition selected from the group consisting of urinary bladder submucosa and stomach submucosa, and extracts and hydrolysates thereof, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhance initiation of the formation vessel-like structures in the graft construct. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally-derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these tissue graft constructs and for preparing these graft constructs are also provided.
Patent AU-2003251206-B2 (AU)
Title: New benzoyl piperidine compounds
Inventor: PARK CHUN-EUNG
IPC: C07D211/32
Filed: 2003-08-19
Granted: 2009-05-28
Abstract: Provided herein are racemic or enantiomerically enriched benzoyl piperidine compounds and pharmaceutically useful salts thereof, pharmaceutical compositions comprising an effective amount of racemic or enantiomerically enriched benzoyl piperidine compounds to treat central nervous system diseases and methods of treating central nervous system diseases in a mammal, in particular psychoses and cognition disorders.
Patent AU-2003258390-B2 (AU)
Title: ACTN3 genotype screen for athletic performance
Inventor: NORTH KATHRYN NANCE
IPC: G16H20/30
Filed: 2003-09-15
Granted: 2008-04-24
Abstract: The present invention concerns novel methods of selecting or matching a sport or sporting event to an individual (e.g. a sprint/power sport or an endurance sport) and predicting athletic performance, the methods involving assessing ACTN3 genotype. In alternative embodiments, training regimens may be optimally designed for athletes by assessing the ACTN3 genotypes. Certain embodiments concern combining the assessment of the ACTN3 genotype with other known fitness-related genes to better assess the athletic potential of an individual. In addition, the genotypic analysis of the ACTN3 gene may be combined with physiological tests, physical measurements and/or psychological assessments to more optimally design a training regimen for an individual athlete.
Patent AU-2003270052-B2 (AU)
Title: Phosphor-coated LED with improved efficiency
Inventor: SOULES THOMAS F
IPC: H01L33/44
Filed: 2003-08-29
Granted: 2009-02-19
Abstract: An LED device including an LED chip and a lens positioned apart from the chip and coated with a uniform thickness layer of fluorescent phosphor for converting at least some of the radiation emitted by the chip into visible light. Positioning the phosphor layer away from the LED improves the efficiency of the device and produces more consistent color rendition. The surface area of the lens is preferably at least ten times the surface area of the LED chip. For increased efficiency, the reflector and submount can also be coated with phosphor to further reduce internal absorption.
Patent AU-2003284064-B2 (AU)
Title: Peelable seal for a multichambered container
Inventor: HOUWAERT VINCENT
IPC: A61J1/20
Filed: 2003-10-14
Granted: 2009-06-04
Abstract: A multichambered container comprising: a first sidewall (44) and an opposing second sidewall (46); a peripheral seal (16) sealing the sidewalls along a common peripheral edge (14); a peelable seal (26) connecting the first sidewall and the second sidewall to form chambers (22,24) in the container; and the peelable seal having a serrated portion (42), the serrated portion not in contact with the peripheral seal.
Patent AU-2003285911-B2 (AU)
Title: 4-methylhexanoic kahalaide F compound
Inventor: MARCHANTE MARIA DEL CARMEN CUEVAS
IPC: C07K7/64
Filed: 2003-10-20
Granted: 2009-11-19
Abstract: The present invention is directed to new kahalalide antitumoral compounds, in particular to analogues of kahalalide F, useful as antitumoral, antiviral, antifungal agents and in the treatment of psoriasis.
Patent AU-2003288022-B2 (AU)
Title: Method for the selective and quantitative functionalization of immunoglobulin Fab fragments, conjugate compounds obtained with the same and compositions thereof
Inventor: MAISANO FEDERICO
IPC: A61K51/10
Filed: 2003-11-10
Granted: 2009-04-30
Abstract: The invention provides chemical conjugates between an immunoglobulin Fab fragment and molecular entities imparting diagnostic or therapeutic utility, whereby the only sites of conjugation on the Fab fragment are one or both of the sulfhydryl groups deriving from the selective and quantitative reduction of the inter-chain disulfide bond of said Fab fragment and whereby said molecular entities imparting diagnostic or therapeutic utility have at least one free sulfhydryl-reactive group, characterized in that the conjugation stoichiometric molar ratio molecular entity to Fab fragment is in the range from 0.95 to 1.05 or in the range from 1.95 to 2.05.  The invention also provides a process for preparing said conjugates and pharmaceutical compositions thereof.
Patent AU-2004213869-B2 (AU)
Title: Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
Inventor: DAVIDSON ROBERT C
IPC: C12N9/10
Filed: 2004-02-20
Granted: 2010-03-04
Abstract: The present invention relates to eukaryotic host cells having modified oligosaccharides which may be modified further by heterologous expression of a set of glycosyltransferases, sugar transporters and mannosidases to become host-strains for the production of mammalian, e.g., human therapeutic glycoproteins. The invention provides nucleic acid molecules and combinatorial libraries which can be used to successfully target and express mammalian enzymatic activities such as those involved in glycosylation to intracellular compartments in a eukaryotic host cell. The process provides an engineered host cell which can be used to express and target any desirable gene(s) involved in glycosylation. Host cells with modified oligosaccharides are created or selected. N-glycans made in the engineered host cells have a Man5GlcNAc2 core structure which may then be modified further by heterologous expression of one or more enzymes, e.g., glycosyltransferases, sugar transporters and mannosidases, to yield human-like glycoproteins. For the production of therapeutic proteins, this method may be adapted to engineer cell lines in which any desired glycosylation structure may be obtained.
Patent AU-2004249661-B2 (AU)
Title: Fastener having improved penetration capability
Inventor: FARRELL MICHAEL E
IPC: F16B15/00
Filed: 2004-03-19
Granted: 2009-03-19
Abstract: A metal piercing fastener having an elongated flat body having first and second surfaces with a heat at one end and a piercing point at the other. The thickness dimension of the flat body is greater proximate the head proximate the point. The first and second surfaces of the body are devoid of protrusions extending outwardly therefrom.
Patent AU-2004262907-B2 (AU)
Title: Medicament dispenser
Inventor: AUGUSTYN STEPHEN
IPC: A61M15/00
Filed: 2004-07-21
Granted: 2011-01-27
Abstract: There is provided a medicament dispenser for containing plural elongate form medicament carriers, each having multiple distinct medicament dose portions carried thereby, the dispenser having a housing of generally non-circular form, and within said housing a dispensing mechanism for dispensing the distinct medicament dose portions carried by each of said plural medicament carriers. The mechanism comprises at least one receiving station for receiving each of the plural medicament carriers; a release for releasing in combination a distinct medicament dose portion from each of the plural medicament carriers on receipt thereof by said receiving station; an outlet, positioned to be in communication with the distinct medicament dose portions releasable by said release; and at least one indexer for individually indexing the distinct medicament dose portions of each of the plural medicament carriers. The dispenser contains plural elongate form medicament carriers, each having multiple distinct dose portions carried thereby. At least one of said medicament carriers has the form of a continuous loop.
Patent AU-2005263882-B2 (AU)
Title: Discharge of fire extinguishing agent
Inventor: SIMPSON GREG
IPC: A62C3/07
Filed: 2005-06-13
Granted: 2012-07-05
Abstract: Apparatus (11) for rapid discharge of one or more fire extinguishing agent(s) comprises a sealed container (13) forming an interior volume (15) in communication with a rapidly opening valve assembly (17). The interior volume contains fire extinguishing agent(s), super-pressurised by a gas such as nitrogen. A portion of the nitrogen is dissolved into the fire extinguishing agent(s). When an incident is detected which requires the discharge of the fire extinguishing agent(s) the valve (17) is opened. Opening the valve (17) causes rapid dissolution of the nitrogen from the fire extinguishing agent(s), forming a two-phase mixture (like a foam or mousse) which substantially fills the volume (15) and causing the discharge of fire extinguishing agent(s) from the valve assembly (17). Because the two phase mixture is used to discharge the fire extinguishing agent(s), and this two phase mixture substantially fills the interior volume (15), the fire extinguishing agent(s) will be discharged irrespective of the orientation of the canister (13) and the position of the valve assembly (17).
Patent AU-2005284729-B2 (AU)
Title: Compositions and methods for inhibiting expression of anti-apoptotic genes
Inventor: HANS-PETER VORNLOCHER
IPC: C12Q1/68
Filed: 2005-09-15
Granted: 2011-12-01
Abstract: The present invention relates to a double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of an anti-apoptotic gene, comprising an antisense strand having a nucleotide sequence which is less that 25 nucleotides in length and which is substantially complementary to at least a part of an apoptotic gene, such as a Bcl gene. The invention also relates to a pharmaceutical composition comprising the dsRNA together with a pharmaceutically acceptable carrier; methods for treating diseases caused by the expression of an anti-apoptotic gene using the pharmaceutical composition; and methods for inhibiting the expression of an anti-apoptotic gene in a cell.
Patent AU-2005303937-B2 (AU)
Title: Process for producing a repair coating on a coated metallic surface
Inventor: ERIKSSON MATS
IPC: C23C22/00
Filed: 2005-11-09
Granted: 2010-11-25
Abstract: A repair coating is produced on a metallic surface by coating the surface with a corrosion protecting coating, at least partially removing the corrosion protecting coating in the area, and applying a thin corrosion protecting coating containing silicon compound. Production of a repair coating on a metallic surface comprises coating the surface with a corrosion protecting coating applied with a composition comprising pretreatment compositions like activating compositions, passivating compositions, phosphating compositions, titanium compound(s) or zirconium compound(s) or both of them containing compositions and after-rinse-compositions, organic compositions like primers, wet-primers, welding primers, e-coats, powder coats, base-coats or clear-coats, or silicon compound(s) containing compositions that are solutions or dispersions containing silanes, silanols, siloxanes or polysiloxanes; at least partially removing the corrosion protecting coating in the area; and applying a thin corrosion protecting coating containing silicon compound with a solution or dispersion containing silane, silanol, siloxane and/or polysiloxane. An independent claim is also included for a tool for carrying out the inventive process.
Patent AU-2005309975-B2 (AU)
Title: Low-complexity film grain simulation technique
Inventor: COOPER JEFFREY ALLEN
IPC: H04N7/26
Filed: 2005-09-26
Granted: 2010-09-16
Abstract: The simulation of film grain in a video image occurs by first creating a block (i.e., a matrix array) of transformed coefficients for a set of cut frequencies fHL, fVL, fHH and fVH associated with a desired grain pattern. (The cut frequencies fHL, fVL, fHH and fVH represent cut-off frequencies, in two dimensions, of a filter that characterizes the desired film grain pattern). The block of transformed coefficients undergoes an inverse transform to yield a bit-accurate film grain sample and the bit accurate sample undergoes scaling to enable blending with a video signal to simulate film grain in the signal.
Patent AU-2005336429-B2 (AU)
Title: EAS system providing synchronized transmission
Inventor: DREW DOUGLAS A
IPC: G08B13/24
Filed: 2005-09-09
Granted: 2010-01-21
Abstract: A system and method for providing synchronized transmission in an electronic article surveillance (EAS) system is provided. The method includes determining a transmission timing difference between a plurality of units of the EAS system using a communication link of the EAS system and synchronizing transmissions for each of the plurality of units based on the transmission timing difference.
Patent AU-2006212191-B2 (AU)
Title: Parametric joint-coding of audio sources
Inventor: FALLER CHRISTOF
IPC: G10L19/008
Filed: 2006-02-13
Granted: 2009-01-15
Abstract: The following coding scenario is addressed: A number of audio source signals need to be transmitted or stored for the purpose of mixing wave field synthesis, multi-channel surround, or stereo signals after decoding the source signals. The proposed technique offers significant coding gain when jointly coding the source signals, compared to separately coding them, even when no redundancy is present between the source signals. This is possible by considering statistical properties of the source signals, the properties of mixing techniques, and spatial hearing. The sum of the source signals is transmitted plus the statistical properties of the source signals which mostly determine the perceptually important spatial cues of the final mixed audio channels. Source signals are recovered at the receiver such that their statistical properties approximate the corresponding properties of the original source signals. Subjective evaluations indicate that high audio quality is achieved by the proposed scheme.
Patent AU-2006255805-B2 (AU)
Title: Use of plant cell membrane for the for the treatment of obesity
Inventor: ALBERTSSON PER-AKE
IPC: A23L33/00
Filed: 2006-06-09
Granted: 2013-02-14
Abstract: Use of a composition comprising cell membrane, or hydrophobic peptides derived from said cell membrane, for the reduction of lipolytic activity, retardation of fat digestion, suppression of appetite, decrease of body weight and/or lowering of blood lipids. Satiety for fat is mainly driven from the intestine. By the contact of fat with the intestinal mucosa, various satiety peptides are released, thus suppressing appetite and food intake. A reduced rate of fat digestion could optimise the satiety for fat, through prolonged release of satiety peptides. Fat digestion can be retarded by reduction of the lipolytic activity of pancreatic lipase. The examples show that fractions of plant cell membranes (thylakoids) inhibit the lipolytic activity of pancreatic lipase.
Patent AU-2006309706-B2 (AU)
Title: Equol level regulator
Inventor: AKAZA HIDEYUKI
IPC: A23L27/30
Filed: 2006-11-02
Granted: 2013-02-14
Abstract: The object is to provide: a pharmaceutical or food/beverage which has an effect of regulating the equol level in the body, is highly safe, and therefore can be ingested for a long period of time; a selection culture medium for a microorganism having an equol converting activity; and a method for detection of the microorganism. Thus, disclosed are: an agent for increasing or decreasing the equol level, which comprises a saccharide as an active ingredient; use of a saccharide for production of the agent; a method for increasing or decreasing the equol level, which comprises administering an effective amount of a saccharide; a selection culture medium for a microorganism having an equol converting activity, which comprises a saccharide; and a method for detection of a microorganism having an equol converting activity by using the culture medium.
Patent AU-2006317434-B2 (AU)
Title: Bacterial antigens and uses thereof
Inventor: RICHARDS JAMES C
IPC: A61K39/095
Filed: 2006-11-23
Granted: 2012-08-30
Abstract: Novel enzymes, processes and antigenic structures useful in producing vaccines and compounds useful in combating gram-negative bacteria are described. Enzymes were isolated from the slime mould and used to specifically degrade lipopolysaccharide (LPS). Enzymatic degradation permits residues of the LPS molecule, including immunogenic epitopes of the core oligosaccharide portion of the LPS, to remain unmodified during this enzymatic removal of fatty acids from the lipid A region of the LPS molecule.
Patent AU-2006332705-B2 (AU)
Title: Tungstate and molybdate wood preservatives
Inventor: SCIALDONE MARK
IPC: B27K3/32
Filed: 2006-12-28
Granted: 2012-02-09
Abstract: Complexes of copper and/or zinc with molybdate and/or tungstate were solubilized in ammonia or ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the ammonia from the wood, the complexes were stably retained in the wood providing a long lasting preservative.
Patent AU-2006336279-B2 (AU)
Title: Bispecific single chain FV antibody molecules and methods of use thereof
Inventor: MARKS JAMES D
IPC: C07K16/44
Filed: 2006-06-14
Granted: 2012-05-17
Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
Patent AU-2006336468-B2 (AU)
Title: Method of expressing proteins with disulfide bridges
Inventor: MINEA RADU
IPC: C07K14/245
Filed: 2006-02-09
Granted: 2012-04-12
Abstract: This invention relates to methods of expressing eukaryotic proteins in prokaryotic hosts, particularly eukaryotic proteins that require formation of disulfide bridges for biological activity. Various approaches are used including fusion to thioredoxin, cytoplasmic expression of disulfide isomerases, deficiencies in thioredoxin and/or glutathione reductases, deficiencies in proteases, and the like. The method is applicable to express monomelic and dimeric forms of the eukaryotic protein with biological activity such as monomeric and dimeric forms of a disintegrin or a disintegrin domain. Included are the vectors, host cells expressing the proteins, the expressed proteins and methods of using the proteins.